Signal26
2024
Signal26 Rebranding
About project
Signal26 Biotherapeutics is a biotechnology startup committed to developing an innovative biological drug for the treatment of Pustular Psoriasis. For their rebranding, we created a strategy centered on a human-oriented approach to autoimmune conditions, emphasizing Signal26’s dedication to improving lives.
Human-oriented
Branding strategy emphasizes the personal impact of the biomedical solutions, focusing on empathy, care, and well-being of people managing chronic conditions.
Rebranding
Our goal was to reflect their mission and values while creating a professional and approachable brand that resonates with patients, researchers, and industry partners alike.
